EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
AZ191 |
DYRK1B抑制剂(AZ191) |
1594092-37-1 |
4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile |
化合物NVP-2 |
1263373-43-8 |
GSK621 |
6-氯-5-(2'-羟基-3'-甲氧基-[1,1'-联苯]-4-基)-3-(3-甲氧基苯基)-1H-吡咯并[3,2-D]嘧啶-2,4(3H,5H)-二酮 |
1346607-05-3 |
N-(4-Mesitylthiazol-2-yl)benzaMide |
N-[4-(2,4,6-三甲基苯基)-2-噻唑基]苯甲酰胺 |
1001753-24-7 |
ABT 263 |
ABT 263 |
923564-51-6 |
SKL 2001 |
SKL2001 |
909089-13-0 |
3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole |
3-(1,3-苯并二恶唑-5-基)-5-(3-溴苯基)-1H-吡唑 |
882697-00-9 |
6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE |
6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶 |
866405-64-3 |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚 |
677297-51-7 |
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE |
(2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺 |
658084-64-1 |
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea |
Ki20227 |
623142-96-1 |
SPDP |
氮-琥珀星氩氨-3(2-吡啶二硫代)-酸酯 |
68181-17-9 |
ethylene dimethanesulfonate |
二甲基磺酸乙烷 |
4672-49-5 |
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% |
4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 |
349085-82-1 |
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester |
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester |
2222114-64-7 |
GR148672X |
GR148672X |
263890-70-6 |
BLU 9931 |
BLU 9931 |
1538604-68-0 |
UNC 1999 |
UNC1999 |
1431612-23-5 |
CEP-32496 (free base) |
CEP 32496 |
1188910-76-0 |